Publications by authors named "Rich Barron"

Claim this Profile
P
Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos).
Jonathan D Adachi, Claudie Berger, Rich Barron, Derek Weycker, Tassos P Anastassiades

Arch Osteoporos· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
Saeko Fujiwara, Akimitsu Miyauchi, Etsuro Hamaya, Rebecca Jayne Nicholls, Adele Weston, Rich Barron

Arch Osteoporos· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
Saeko Fujiwara, Akimitsu Miyauchi, Etsuro Hamaya, Rebecca Jayne Nicholls, Adele Weston, Rich Barron

Arch Osteoporos· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.
Derek Weycker, David Chandler, Rich Barron, Hairong Xu, Hongsheng Wu

J Oncol Pharm Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes.
Derek Weycker, Xiaoyan Li, Rich Barron, Rebecca Bornheimer, David Chandler

Bone Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.
Sarah Mitchell, Xiaoyan Li, Matthew Woods, Jacob Garcia, Kerri Hebard-Massey, Rich Barron

J Oncol Pharm Pract· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice.
Derek Weycker, Xiaoyan Li, Rich Barron, Yanli Li, Maureen Reiner

Support Care Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
Derek Weycker, Xiaoyan Li, Jacqueline Figueredo, Rich Barron, Spiros Tzivelekis

Support Care Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use.
Derek Weycker, Xiaoyan Li, Rich Barron, Hongsheng Wu, P K Morrow

J Natl Compr Canc Netw· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.
Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov

J Oncol Pract· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens.
Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov

Support Care Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.
Derek Weycker, Rich Barron, John Edelsberg, Alex Kartashov, Jason Legg

BMC Health Serv Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of antibiotic resistance in US hospitals.
John Edelsberg, Derek Weycker, Rich Barron, Xiaoyan Li, Hongsheng Wu

Diagn Microbiol Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs associated with febrile neutropenia in the US.
Shannon L Michels, Rich L Barron, Matthew W Reynolds, Karen Smoyer Tomic, Jingbo Yu

Pharmacoeconomics· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.
Derek Weycker, John Edelsberg, Alex Kartashov, Rich Barron, Gary Lyman

Chemotherapy· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy.
Derek Weycker, Jennifer Malin, Rich Barron, John Edelsberg, Alex Kartashov

Am J Clin Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice.
Derek Weycker, Rich Barron, John Edelsberg, Alex Kartashov, Gary H Lyman

Breast Cancer Res Treat· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
Hiangkiat Tan, Karen Tomic, Dana Hurley, Gregory Daniel, Rich Barron

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of mortality in patients with cancer who experience febrile neutropenia.
Gary H Lyman, Shannon L Michels, Matthew W Reynolds, Rich Barron, Karen Smoyer Tomic

Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence.
Ulka B Campbell, Paul Stang, Rich Barron

Value Health· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
Derek Weycker, Jennifer Malin, John Kim, Rich Barron, John Edelsberg

Clin Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Perceptions of Physician-Patient Discussions and Adverse Events with Cancer Therapy.
Dawn Hershman, Elizabeth Calhoun, Kinga Zapert, Shawn Wade, Jennifer Malin, Rich Barron

Arch Drug Inf· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Mary Ann Chapman, Rich Barron, David C Tanis, Chandler E Gill, P David Charles

Clin Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence.
Brigitte Schurch, Pierre Denys, Chris M Kozma, Pat Ray Reese, Terra Slaton, Rich Barron

Arch Phys Med Rehabil· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of repeated treatment with botulinum toxin type A across different conditions.
Mark Forrest Gordon, Rich Barron

South Med J· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis